covid-19

With more than six months of COVID-19 disruptions behind us, there have been some clear winners emerging as a result of changes in spending patterns and the shift to...

It hasn’t been a good year for Avita Therapeutics (ASX:AVH). The med-tech stock is the worst performer among Livewire readers’ 10 most-tipped small caps, down nearly...

Retail has been one of the surprise winners from the pandemic, capturing the attention of savvy investors. But just as important as identifying winners, is avoiding...

Melbourne-based biotech Mesoblast will achieve a world-first that could open up its drug pipeline to a massive market if it wins US Food and Drug Administration...

COVID-19 has well and truly slashed Australia’s residential property market. What was a consistent market, moving 10% either upwards or downwards for the past three...

In the latest episode of our Complexity Premia podcast, portfolio management director Ying Yi and I discuss a range of interesting topics, including: how you can turn...

The latest Listed Managed Investments Monthly for July 2020 focuses on the implied default rates of each debt listed investment trust and compares these figures to...

In the AFR this weekend I write that it now appears Victoria’s tragic second wave peaked around July 31. In early July we started applying our internal forecasting...

At last Friday’s parliamentary appearance, RBA Governor Lowe said that the activity restrictions imposed in Victoria in response to the resurgence of Covid-19 cases...

As with everything else, there are two camps when it comes to investment conditions today. There are two camps regarding whether the market is expensive (it probably...